TB Trifusion Antigen Adsorbed on Calcium Phosphate Nanoparticles Stimulates Strong Cellular Immunity in Mice

다국어 초록 (Multilingual Abstract)

Among various vaccine candidates, subunit vaccines play an important role in immune protection against tuberculosis (TB). Calcium phosphate (CP) is considered as a strong inorganic adjuvant due to its great potential in increasing immune responses. The purpose of this study was to evaluate specific immune responses following the administration of trifusion-CP nanoparticles.
The physiochemical properties of these nanoparticles, including morphology, particle size, zeta potential and adsorption rate, were measured in vitro. Subcutaneous immunization was performed three times on days 0, 14, and 28. Two weeks after the last administration, IFN-gamma, IL-4, and TGF-beta levels were measured by indirect enzyme linked immunosorbent assay (ELISA). The trifusion protein was successfully adsorbed onto calcium phosphate nanoparticles. The mean sizes of the resultant trifusion- CPN and CPN were 97.84 ± 12.08 and 67 ± 11.85 nm, respectively. CPN containing trifusion had stronger ability to induce IFN-gamma than the control groups. IL-4 and TGF-beta secretions in trifusion and trifusion-CPN groups were higher than those in the PBS group. However, there was no significant (p > 0.05) difference in IL-4 and TGFbeta concentrations between trifusion group and trifusion- CPN group. Therefore, calcium phosphate nanoparticles are good candidates for immunization against TB because antigen can be easily adsorbed onto CPN and strong cellular immune responses against CPN-antigen can be stimulated.

참고문헌 (Reference)

1 Montagnani, C., "Vaccine against tuberculosis: What’s new?" 14 : S2-, 2014

2 Pitt, J. M, "Vaccination against tuberculosis: How can we better BCG? Microbial" 58 : 2-16, 2013

3 Knudsen, N. P. H, "Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics" 111 : 1096-1101, 2014

4 Berridge, M. J., "The versatility and universality of calcium signalling" 1 : 11-21, 2000

5 Sokolova, V., "The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation" 31 : 5627-5633, 2010

6 Andersen, P, "The success and failure of BCG—implications for a novel tuberculosis vaccine" 3 : 656-662, 2005

7 Chan, J., "The role of B cells and humoral immunity in Mycobacterium tuberculosis infection" 26 : 588-600, 2014

8 Lin, P. L, "The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection" 122 : 303-, 2012

9 Zelphati, O, "Stable and monodisperse lipoplex formulations for gene delivery" 5 : 1272-1282, 1998

10 Seenuvasan, M., "Response surface estimation and canonical quantification for the pectin degrading Fe3O4-SiO2 nanobiocatalyst fabrication" 6 : 3618-3627, 2014

11 Ahsan, M. J, "Recent advances in the development of vaccines for tuberculosis" 3 : 66-75, 2015

12 Jones, S., "Protein coated microcrystals formulated with model antigens and modified with calcium phosphate exhibit enhanced phagocytosis and immunogenicity" 32 : 4234-4242, 2014

13 Tafaghodi, M., "Preparation and in vivo study of dry powder microspheres for nasal immunization" 18 : 235-242, 2010

14 Xiang, S. D., "Pathogen recognition and development of particulate vaccines: Does size matter?" 40 : 1-9, 2006

15 Manolova, V., "Nanoparticles target distinct dendritic cell populations according to their size" 38 : 1404-1413, 2008

16 Niu, H., "Multi-stage tuberculosis subunit vaccine candidate LT69 provides high protection against Mycobacterium tuberculosis infection in mice" 10 : e0130641-, 2015

17 Hanif, S., "Molecular cloning, expression, purification and immunological characterization of three low-molecular weight proteins encoded by genes in genomic regions of difference of mycobacterium Tuberculosis" 71 : 353-361, 2010

18 Mahmood, A., "Molecular characterization of secretory proteins Rv3619c and Rv3620c from Mycobacterium tuberculosis H37Rv" 278 : 341-353, 2011

19 Aronson, N. E., "Longterm efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study" 291 : 2086-2091, 2004

20 Bonanni, D, "Immunogenicity of mycobacterial PPE44 (Rv2770c) in Mycobacterium bovis BCG-infected mice" 54 : 443-448, 2005

21 Romano, M., "Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c)" 26 : 6053-6063, 2008

22 Knuschke, T., "Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection" 190 : 6221-6229, 2013

23 Tafaghodi, M., "Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental Autoclaved Leishmania major (ALM) and Quillajasaponins" 27 : 639-650, 2010

24 Rook, G. A., "Immune responses to tuberculosis in developing countries: Implications for new vaccines" 5 : 661-667, 2005

25 Cuccu, B., "Identification of a human immunodominant T-cell epitope of mycobacterium tuberculosis antigen PPE44" 11 : 167-, 2011

26 Relyveld, E., "Humoral response in rabbits immunized with calcium phosphate adjuvanted HIV-1 gp160antigen" 48 : 79-83, 1994

27 Gagneux, S, "Host–pathogen coevolution in human tuberculosis" 367 : 850-859, 2012

28 Epple, M., "Functionalized calcium phosphate nanoparticles for biomedical application" 441 : 299-305, 2010

29 Seenuvasan, M., "Fabrication, characterization and application of pectin degrading Fe3O4-SiO2 nanobiocatalyst" 33 : 2273-2279, 2013

30 Marongiu, L, "ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation" 8 : e75684-, 2013

31 Brandt, L., "ESAT-6 Subunit Vaccination against Mycobacterium tuberculosis" 68 : 791-795, 2000

32 Costello, A. d. L, "Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis? Trans" 86 : 686-692, 1992

33 Torrado, E., "Differential and site specific impact of B cells in the protective immune response to Mycobacterium tuberculosis in the mouse" 8 : 2013

34 Mustafa, A. S, "Development of new vaccines and diagnostic reagents against tuberculosis" 39 : 113-119, 2002

35 Amini, Y, "Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6antigen" 28 : 1-6, 2016

36 Hu, Y., "Deletion of the Mycobacterium tuberculosis α-crystallin-like hspX gene causes increased bacterial growth in vivo" 74 : 861-868, 2006

37 Ryan, N. J, "Delamanid: First global approval" 74 : 1041-1045, 2014

38 He, Q, "Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2" 9 : 1021-1024, 2002

39 He, Q., "Calcium phosphate nanoparticle adjuvant" 7 : 899-903, 2000

40 Koppad, S., "Calcium phosphate coupled Newcastle disease vaccine elicits humoral and cell mediated immune responses in chickens" 91 : 384-390, 2011

41 Achkar, J. M., "B cells and antibodies in the defense against Mycobacterium tuberculosis infection" 264 : 167-181, 2015

42 Cohen, J., "Approval of novel TB drug celebrated-with restraint" 339 : 130-130, 2013

43 Nelson, L., "Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002" 366 : 488-490, 2005

44 Behera, T., "Antigen adsorbed calcium phosphate nanoparticles stimulate both innate and adaptive immune response in fish, Labeo rohita H" 271 : 350-359, 2011

45 Lindblad, E. B., "Aluminium adjuvants-in retrospect and prospect" 22 : 3658-3668, 2004

46 Singh, M., "A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens" 24 : 1680-1686, 2006

47 Yuan, X, "A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection" 99 : 10587-10595, 2015